沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

圣诞节休市 12-24 12:08:24

6.410

+0.190

+3.05%

最高6.450	最低6.210	成交量74.57万
今开6.240	昨收6.220	日振幅3.86%
总市值43.01亿	流通市值43.01亿	总股本6.71亿
成交额471.99万	换手率0.11%	流通股本6.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":6.41,"timestamp":1766549304011,"preClose":6.22,"halted":0,"volume":745736,"delay":0,"floatShares":671000000,"shares":671000000,"eps":-0.375493480252261,"marketStatus":"圣诞节休市","change":0.19,"latestTime":"12-24 12:08:24","open":6.24,"high":6.45,"low":6.21,"amount":4719851,"amplitude":0.038585,"askPrice":6.41,"askSize":15000,"bidPrice":6.35,"bidSize":218000,"shortable":3,"etf":0,"ttmEps":-0.3769535989175487,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":6.22,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":1.3284365993408753,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2593447932","title":"科华生物最新公告：控股子公司产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447932","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447932?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:50","pubTimestamp":1766573440,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称，近日，公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证。该产品为人类ALDH2基因多态性检测试剂盒（荧光PCR法），注册证编号为国械注准20253402670，有效期至2030年12月22日。该试剂盒用于体外定性检测人全血样本基因组DNA中ALDH2基因c.1510G>A位点的多态性。新产品的取得丰富了公司产品线，对公司业务发展具有正面影响，但对未来营业收入的影响尚无法预测。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400031354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0239","BK0028","159883","BK1100","09996","BK0046","BK1222","09997","BK0188","002022","BK1574"],"gpt_icon":0},{"id":"2593475762","title":"安杰思(688581.SH)子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593475762","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593475762?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:01","pubTimestamp":1766570500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安杰思(688581.SH)发布公告，近日，公司的控股子公司杭安医学科技(杭州)有限公司(简称“杭安医学”)获得浙江省药品监督管理局颁发的医疗器械注册证。产品名称分别为：电子内窥镜图像处理器、上消化道电子内窥镜、下消化道电子内窥镜。上述医疗器械注册证的取得，进一步丰富了公司在内镜领域诊疗领域的产品线，不断满足多元化的临床需求，有助于提高公司的市场综合竞争力，对公司的可持续发展将产生积极的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688581","BK1574","BK1100","BK1583","159883","09996","BK0251","09997","BK1222"],"gpt_icon":0},{"id":"2593756624","title":"三诺生物（300298）披露取得医疗器械注册证，12月24日股价上涨0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756624","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593756624?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:52","pubTimestamp":1766569946,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，三诺生物报收于17.14元，较前一交易日上涨0.71%，最新总市值为96.03亿元。该股当日开盘17.02元，最高17.16元，最低16.96元，成交额达7835.09万元，换手率为1.02%。公司近日发布公告称，三诺生物传感股份有限公司近日获得湖南省药品监督管理局颁发的四项医疗器械注册证。其中，血糖尿酸血酮分析仪为新获批注册证，其余三项为延续注册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400029162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159883","BK0102","BK1100","BK1222","BK0114","BK1583","09996","09997","300298","BK0251"],"gpt_icon":0},{"id":"2593427518","title":"九强生物(300406.SZ)取得三项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593427518","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593427518?lang=zh_cn&edition=full","pubTime":"2025-12-24 15:48","pubTimestamp":1766562483,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，涉及产品：“D-二聚体校准品”、“降钙素测定试剂盒(磁微粒化学发光免疫分析法)”、“霉酚酸测定试剂盒(IMPDHⅡ法)”。上述产品医疗器械注册证的取得，丰富了公司在体外诊断生化、化学发光及血凝细分领域产品线的品种，有利于进一步提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK1100","BK1574","BK1583","BK0239","BK1222","300406","159883","09996","BK0012","09997","BK0028","BK0046"],"gpt_icon":0},{"id":"2593441524","title":"亚辉龙（688575）披露取得医疗器械注册证，12月23日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593441524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593441524?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:25","pubTimestamp":1766499909,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，亚辉龙报收于14.26元，较前一交易日下跌0.77%，最新总市值为81.48亿元。该股当日开盘14.38元，最高14.44元，最低14.21元，成交额达4380.86万元，换手率为0.54%。公司近日发布公告称，深圳市亚辉龙生物科技股份有限公司及全资子公司湖南亚辉龙生物科技有限公司近日分别收到广东省药品监督管理局和湖南省药品监督管理局签发的医疗器械注册证。截至目前，公司已取得257个化学发光试剂国内注册证，其中180项为全自动化学发光试剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300040409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","09996","159883","BK1100","BK1222","BK1583","BK1574","688575","BK0239"],"gpt_icon":0},{"id":"2593413090","title":"复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413090","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593413090?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:08","pubTimestamp":1766498900,"startTime":"0","endTime":"0","summary":"证券日报网讯12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599787764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","09997","BK4581","BK0175","BK1222","LABU","BK0060","600196","02196","BK1583","159883","BK0183","09996","01477","BK1191","BK0187","BK0188","159760","BK4585","BK0028","BK0196","BK1574","BK0096","BK0239","XBI","BK4588","BK1593","XLV","BK1100","BK0012"],"gpt_icon":0},{"id":"2593499851","title":"亚辉龙(688575.SH)及子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593499851","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593499851?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:05","pubTimestamp":1766484305,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚辉龙(688575.SH)发布公告，公司及全资子公司湖南亚辉龙生物科技有限公司于近日分别收到了由广东省药品监督管理局和湖南省药品监督管理局签发的医疗器械注册证，产品名称：涎液化糖链抗原(KL-6)测定试剂盒(化学发光法)、抗黑色素瘤分化相关基因5IgG抗体测定试剂盒(化学发光法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","09996","BK1574","BK0239","159883","BK1222","BK1583","688575","BK1100"],"gpt_icon":0},{"id":"2593447039","title":"每日卖空追踪 | 沛嘉医疗-B 12月23日卖空量成交8.1万股，卖空比例为4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447039?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:30","pubTimestamp":1766478642,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间12月23日，涨3.15%，卖空量成交8.1万股，较上一交易日增加268.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163626a6c5209c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163626a6c5209c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2593640394","title":"吉林通报不合格医疗器械 大安爱尔眼科眼部热敷贴登榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2593640394","media":"中金财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593640394?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:57","pubTimestamp":1766473024,"startTime":"0","endTime":"0","summary":"中国经济网北京12月23日讯 吉林省药品监督管理局网站近期发布吉林省医疗器械质量公告 。为加强医疗器械质量监督管理，保障医疗器械产品使用安全有效，吉林省药品监督管理局在全省范围内组织开展质量抽查检验，现将本期不合格产品信息予以公告。药品监督管理部门已要求相关单位采取风险防控措施，对不合格产品依据相关法律法规进行查处。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31884513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1242518931.SGD","300015","LU0979878070.USD","BK1222","BK1100","LU1146622755.USD","LU1242518857.USD","BK0096","LU1820825898.SGD","BK0114","09997","BK0012","09996","BK0028","BK0077","BK1574","159883","BK0113","BK0196","BK0236","BK0200","BK0188","BK1583"],"gpt_icon":0},{"id":"2593447209","title":"医疗器械行业行业研究：第六批医用耗材国采文件发布，规则细节及报量符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447209","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447209?lang=zh_cn&edition=full","pubTime":"2025-12-23 12:06","pubTimestamp":1766462777,"startTime":"0","endTime":"0","summary":"事件2025 年 12 月 22 日，国家组织高值医用耗材联合采购办公室发布《国家组织药物涂层球囊类、泌尿介入类医用耗材集中带量采购文件》的公告，企业申报材料递交及信息公开将在 2026 年 1 月 13 日进行。规则一中选企业同时须满足： 竞价比价价格<同竞价单元“锚点价格” 1.5 倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223120626a6c42f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223120626a6c42f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1222","BK1100","09997","BK1587","BK1583","06669","BK1574"],"gpt_icon":0},{"id":"2593211485","title":"东方海洋（002086）披露全资子公司取得医疗器械注册证，12月22日股价下跌0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593211485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593211485?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:53","pubTimestamp":1766397185,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，东方海洋报收于2.4元，较前一交易日下跌0.41%，最新总市值为47.01亿元。该股当日开盘2.42元，最高2.42元，最低2.4元，成交额达7200.52万元，换手率为1.89%。公司近日发布公告称，其全资子公司艾维可生物科技有限公司自主研发的降钙素原测定试剂盒已取得山东省药品监督管理局颁发的医疗器械注册证，注册证编号为鲁械注准20252400747，有效期至2030年12月10日。该产品适用于体外定量检测人血清、血浆、全血中的降钙素原含量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0213","09997","BK1222","BK1583","BK0046","09996","BK1100","159883","002086","BK1574","BK0092"],"gpt_icon":0},{"id":"2593107719","title":"东方海洋(002086.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593107719","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593107719?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391307,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司全资子公司艾维可生物科技有限公司自主研发的降钙素原(PCT)测定试剂盒(荧光免疫层析法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。上述产品获准上市，进一步丰富了艾维可生物科技有限公司在临床检测领域的产品线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK1100","BK1574","002086","09997","09996","BK1222","BK0092","159883","BK0213","BK1583"],"gpt_icon":0},{"id":"2593109015","title":"脑机接口医疗器械工作推进会召开；官方成立南极磷虾油事件调查组 | 健讯Daily","url":"https://stock-news.laohu8.com/highlight/detail?id=2593109015","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593109015?lang=zh_cn&edition=full","pubTime":"2025-12-22 07:42","pubTimestamp":1766360520,"startTime":"0","endTime":"0","summary":"国家药监局在北京召开脑机接口医疗器械工作推进会12月19日消息，国家药监局12月18日在北京召开脑机接口医疗器械工作推进会。下一步将根据调查结果依法依规进行严肃查处，坚决保护消费者合法权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222074642a467b9a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222074642a467b9a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1574","09997","09996","BK1222","00512","BK1191","BK1583"],"gpt_icon":0},{"id":"2593260651","title":"亚虹医药：APLD-2304申报欧洲医疗器械注册获接收","url":"https://stock-news.laohu8.com/highlight/detail?id=2593260651","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593260651?lang=zh_cn&edition=full","pubTime":"2025-12-21 15:51","pubTimestamp":1766303467,"startTime":"0","endTime":"0","summary":"亚虹医药(688176.SH)公告称，公司产品APLD-2304向欧盟公告机构提交了医疗器械注册申请材料，并获得欧盟公告机构接收，后续尚需通过欧盟公告机构的审评、审批后方可上市销售。APLD-2304 是公司针对膀胱癌诊断及随访监测的使用场景和需求，研发的世界上首款便携式一次性蓝光膀胱软镜。由于产品的研发周期长、审批环节多、研发投入大，容易受到一些不确定性因素的影响，对公司近期业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122100001531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK0239","09996","688176","BK1222","BK1100","BK1583","BK1574","159883"],"gpt_icon":0},{"id":"2592019874","title":"戴维医疗（300314）披露全资子公司申报医疗器械注册获得受理，12月19日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592019874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592019874?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:48","pubTimestamp":1766155711,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘，戴维医疗报收于12.91元，较前一交易日上涨0.7%，最新总市值为37.18亿元。该股当日开盘12.76元，最高12.96元，最低12.74元，成交额达2686.75万元，换手率为1.45%。公司近日发布公告称，其全资子公司宁波维尔凯迪医疗器械有限公司申报的一次性腔镜用电动直线型切割吻合器及组件已获浙江省药品监督管理局受理，受理号为械受20254041167。目前该事项处于注册申请受理阶段，后续需经技术审评、行政审批和制证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900040042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09997","BK0048","BK0046","BK0251","159883","BK1222","09996","BK0042","BK1100","300314","BK1583"],"gpt_icon":0},{"id":"2592163072","title":"透景生命(300642.SZ)子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2592163072","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592163072?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:45","pubTimestamp":1766141114,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)公告，公司全资子公司上海透景诊断科技有限公司近日取得上海市药品监督管理局颁发的5项医疗器械注册证，产品包括：抗双链DNA抗体IgG测定试剂盒(流式荧光发光法)、抗补体1q抗体IgG测定试剂盒(流式荧光发光法)、抗M2-3E抗体IgG测定试剂盒(流式荧光发光法)、抗磷脂综合征IgA抗体测定试剂盒(流式荧光发光法)、抗核小体抗体IgG测定试剂盒(流式荧光发光法)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383832.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300642","BK1574","09996","09997","BK0046","BK1583","159883","BK1222","BK0042","BK0239","BK1100"],"gpt_icon":0},{"id":"2592157178","title":"四川宜宾召开2025年医疗器械不良事件报告质量评估会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2592157178","media":"中国消费网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592157178?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:59","pubTimestamp":1766134740,"startTime":"0","endTime":"0","summary":"中国消费者报成都讯 12月17日，四川省宜宾市药品不良反应监测中心组织召开2025年医疗器械不良事件报告质量评估会议。宜宾市属医疗机构、各区县医疗器械监测专家以及相关工作人员参会。宜宾市市场监管局供图会议解读了《四川省医疗器械不良事件严重报告质量评估计分标准（试行）》。评分人员依据《计分标准》对随机抽取的260份报告进行交叉评分，并对质量评估结果进行了现场通报和交流讨论。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-12-19/doc-inhcipui7678836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09996","09997","159883","BK1222","BK1583","BK1100"],"gpt_icon":0},{"id":"2592132485","title":"港股异动 | 脑机接口概念股午前拉升 国家药监局在北京召开脑机接口医疗器械工作推进会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592132485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592132485?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:51","pubTimestamp":1766116260,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，脑机接口概念股午前拉升，截至发稿，南京熊猫涨4.16%，报4.51港元；微创脑科学涨4.24%，报10.83港元；脑动极光-B涨2.58%，报5.96港元。消息面上，国家药监局12月18日在北京召开脑机接口医疗器械工作推进会。国泰海通指出，伴随技术创新突破、政策支持引导、资本投入等多重因素驱动，脑机接口行业有望迎来重要发展机遇，有望在医疗健康、生活消费等下游市场迎来需求释放，市场前景可期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1222","BK1574","BK1149","06681","BK1100","09997","159883","02172","BK1583","09996","00553"],"gpt_icon":0},{"id":"2592236902","title":"戴维医疗（300314）披露全资子公司部分医疗器械产品完成延续注册，12月18日股价上涨2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592236902","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592236902?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:42","pubTimestamp":1766068946,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，戴维医疗报收于12.82元，较前一交易日上涨2.15%，最新总市值为36.92亿元。该股当日开盘12.45元，最高12.91元，最低12.45元，成交额达3777.55万元，换手率为2.06%。公司近日发布公告称，其全资子公司宁波维尔凯迪医疗器械有限公司取得浙江省药品监督管理局颁发的《医疗器械注册证》，产品一次性使用腔镜切割吻合器及组件完成延续注册，注册证编号为浙械注准20162021053，有效期至2031年7月19日。延续注册完成后，维尔凯迪可继续生产和销售该产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","BK0046","BK1222","BK0048","159883","BK0042","09997","300314","BK0251","09996","BK1100"],"gpt_icon":0},{"id":"2592743559","title":"南京医药最新公告：拟1.2亿元参设南药医疗器械投资公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2592743559","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592743559?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:52","pubTimestamp":1766051533,"startTime":"0","endTime":"0","summary":"南京医药公告称，公司拟与南京新工新兴产业投资管理有限公司、南京新工医疗健康强链并购股权投资基金合伙企业共同投资设立南京新工南药医疗器械强链并购股权投资有限责任公司，其中公司拟出资1.2亿元，占南药医疗器械投资公司认缴出资总额的59.9%。南药医疗器械投资公司成立后，专项用于投资宁波江丰生物信息技术有限公司。南药医疗器械投资公司将以江丰生物整体估值不超过7.5亿元为前提受让江丰生物约22.5%的股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800027420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1574","BK1100","BK1583","159883","600713","BK0209","BK1222","09996","BK0250"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.1187},{"period":"1month","weight":0.2049},{"period":"3month","weight":0.0175},{"period":"6month","weight":0.0031},{"period":"1year","weight":0.6106},{"period":"ytd","weight":0.6106}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.088172},{"month":2,"riseRate":0.6,"avgChangeRate":0.039503},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.096159}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}